TW
Towa Pharmaceutical Co., Ltd.
TWAPF · OTC
$25.98 +0.00% (+$0.00)
Market Cap ¥199.6B
P/E Ratio 24.21x
Div. Yield 2.01%
ROE 4.52%
Bulios Fair Price
$31.59
21.6% upside
Current Price
$25.98
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TWAPF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
66 /100
Fair P/E 24.21x
EV/EBITDA 7.62x
P/S 0.71x
Growth
73 /100
Growing EPS growth 6.85%
Rev. growth 16.16%
Book val. growth 9.10%
Profitability
35 /100
Moderate Gross margin 36.26%
Net margin 2.93%
Op. margin 8.71%
Quality
21 /100
Poor ROIC 2.85%
ROE 4.52%
ROA 1.73%
Debt
58 /100
Moderate Debt/Equity 1.26x
Current ratio 2.82x
Int. coverage 11.83x
Stability
57 /100
Moderate Beta -0.09x
Rev. volatility 8.76%
EPS volatility 389.69%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TWAPF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Itsuro Yoshida
Employees
4,923
Headquarters
Kadoma
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
16 NOV
Earnings
Upcoming earnings report
30 MAR
Ex-Dividend
Ex-dividend date
30 MAR
Dividend Payment
Payment date